Cargando…
S-Calprotectin (S100A8/S100A9): A Potential Marker of Inflammation in Patients with Psoriatic Arthritis
Objective. To analyse levels of S100A8/S100A9 (calprotectin) and selected cytokines, in blood, in patients with psoriatic arthritis (PsA). Methods. Sixty-five patients with PsA were examined for clinical manifestations and laboratory measurements of S-calprotectin, ESR, hs-CRP, and selected cytokine...
Autores principales: | Hansson, Claes, Eriksson, Catharina, Alenius, Gerd-Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053083/ https://www.ncbi.nlm.nih.gov/pubmed/24955375 http://dx.doi.org/10.1155/2014/696415 |
Ejemplares similares
-
From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis
por: Inciarte-Mundo, José, et al.
Publicado: (2022) -
An Inflammation Loop Orchestrated by S100A9 and Calprotectin Is Critical for Development of Arthritis
por: Cesaro, Annabelle, et al.
Publicado: (2012) -
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis
por: Chimenti, Maria Sole, et al.
Publicado: (2016) -
Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy
por: Gernert, Michael, et al.
Publicado: (2022) -
Calprotectin (S100A8/A9) in Familial Mediterranean Fever
por: Pepper, R, et al.
Publicado: (2015)